The effective components of Huanglian Jiedu Decoction against sepsis evaluated by a lipid A-based affinity biosensor
- PMID: 27045865
- DOI: 10.1016/j.jep.2016.03.064
The effective components of Huanglian Jiedu Decoction against sepsis evaluated by a lipid A-based affinity biosensor
Abstract
Ethnopharmacological relevance: Huanglian Jiedu Decoction (HJD), the classical recipe for relieving fever and toxicity, has been used for treating sepsis in China for sixteen years. However, the effective components of HJD have not been elucidated until now. Therefore, there is a need to elucidate the effective components of HJD against sepsis on animal models induced by endotoxin (LPS). The affinity force of the effective components of HJD with lipid A was evaluated by a biosensor.
Materials and methods: Lipid A is regarded as the bioactive center of LPS and is always used as a drug target. In order to obtain the effective components of HJD against sepsis, seven fractions from HJD were tested by a biosensor method for assessing the affinity for lipid A. After further separation, the components were isolated from high lipid A-binding fractions and their affinities to lipid A were assessed with the aid of a biosensor. Their activities were then assayed by an in vivo experiment administered through a tail vein injection. The levels of LPS, TNF-α, and IL-6 from the blood were found and pathology experiments were performed.
Results: Three out of the seven fractions exhibited high lipid A-binding affinities. Berberine, baicalin and geniposide were obtained from the three high lipid A-binding fractions. The animal experiments indicated that the levels of LPS, TNF-α and IL-6 in the medicated treatment groups were much lower than that of the model group ((**)P<0.01). The medicated treatment groups exhibited stronger protective activities on varying organs in the animal model.
Conclusions: Berberine, baicalin and geniposide could neutralize LPS by binding with lipid A and then reduce the release of IL-6 and TNF-α induced by LPS. Furthermore, berberine, baicalin and geniposide exhibited protective activities on varying organs compared to the animal model established by the LPS-induced. These results validate that the components from HJD neutralized LPS and then depressed the release of IL-6 and TNF-α induced by LPS. This gives further evidence that HJD would be a suitable treatment for sepsis and protecting vital organs.
Keywords: Biosensor method; Huanglian Jiedu Decoction; Lipid A; Sepsis; The effective components.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
The anti-sepsis activity of the components of Huanglian Jiedu Decoction with high lipid A-binding affinity.Int Immunopharmacol. 2017 May;46:87-96. doi: 10.1016/j.intimp.2017.02.025. Epub 2017 Mar 6. Int Immunopharmacol. 2017. PMID: 28278436
-
Evaluation of anti-sepsis activity by compounds with high affinity to lipid a from HuanglianJiedu decoction.Immunopharmacol Immunotoxicol. 2017 Dec;39(6):364-370. doi: 10.1080/08923973.2017.1380661. Epub 2017 Oct 4. Immunopharmacol Immunotoxicol. 2017. PMID: 28975862
-
[Screening of Active Fractions from Huanglian Jiedu Decoction against Primary Neuron Injury after Oxygen-Glucose Deprivation].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Aug;35(8):981-7. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015. PMID: 26485915 Chinese.
-
Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.J Ethnopharmacol. 2009 Oct 29;126(1):5-17. doi: 10.1016/j.jep.2009.08.009. Epub 2009 Aug 15. J Ethnopharmacol. 2009. PMID: 19686830 Review.
-
Therapeutic interventions in sepsis: current and anticipated pharmacological agents.Br J Pharmacol. 2014 Nov;171(22):5011-31. doi: 10.1111/bph.12829. Epub 2014 Sep 5. Br J Pharmacol. 2014. PMID: 24977655 Free PMC article. Review.
Cited by
-
The interaction of MD-2 with small molecules in huanglian jiedu decoction play a critical role in the treatment of sepsis.Front Pharmacol. 2022 Sep 9;13:947095. doi: 10.3389/fphar.2022.947095. eCollection 2022. Front Pharmacol. 2022. PMID: 36160407 Free PMC article.
-
New strategies for identifying and masking the bitter taste in traditional herbal medicines: The example of Huanglian Jiedu Decoction.Front Pharmacol. 2022 Aug 17;13:843821. doi: 10.3389/fphar.2022.843821. eCollection 2022. Front Pharmacol. 2022. PMID: 36060004 Free PMC article.
-
Detecting Critical Functional Ingredients Group and Mechanism of Xuebijing Injection in Treating Sepsis.Front Pharmacol. 2021 Dec 6;12:769190. doi: 10.3389/fphar.2021.769190. eCollection 2021. Front Pharmacol. 2021. PMID: 34938184 Free PMC article.
-
The Anti-Inflammatory and Anti-Pruritus Mechanisms of Huanglian Jiedu Decoction in the Treatment of Atopic Dermatitis.Front Pharmacol. 2021 Dec 2;12:735295. doi: 10.3389/fphar.2021.735295. eCollection 2021. Front Pharmacol. 2021. PMID: 34925005 Free PMC article.
-
Huanglian Jiedu Decoction for treatment of multiple myeloma: A protocol for a systematic review and meta-analysis.Medicine (Baltimore). 2020 Dec 18;99(51):e22378. doi: 10.1097/MD.0000000000022378. Medicine (Baltimore). 2020. PMID: 33371054 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
